Share your insight and experience to improve patent prosecution in biotechnology areas at the United States Patent and Trademark Office’s (USPTO) next Biotechnology, Chemical, and Pharmaceutical (BCP) Customer Partnership Meeting on Thursday, September 7, from 10 a.m. to 5 p.m. ET. The meeting will be held in person at the USPTO headquarters in Alexandria, Virginia, and online.
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality of the agency’s products and services. The meeting’s discussion topics include:
- Summary of Amgen v. Sanofi
- 35 U.S.C. 112(a)
- Reexamination
- Best practices to help growth stage companies build their IP portfolio
- Patent Center and DOCX
- Common sequence compliance errors
The USPTO looks forward to hearing the individual views of its customers and does not intend to use this forum to seek or arrive at any consensus advice.
Advanced registration is required. Once registered, you will be emailed instructions for joining the BCP.
BCP Customer Partnership
10:00 AM - 5:00 PM Thursday, September 7, 2023
Join link: https://uspto.webex.com/uspto/j.php?MTID=m83975a4888cc2106adb743333a2577e1
Webinar number: 2760 399 6412
Webinar password: virtual (8478825 from phones and video systems)
For more information, please email USPTOBCP1600@USPTO.GOV. Captioning service will be provided.
Accessibility accommodation
If you are an individual with a disability and would like to request a reasonable accommodation, please submit your request to the contact information listed above.